Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Return on Equity (2023 - 2025)

Historic Return on Equity for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to 0.46%.

  • Compass Therapeutics' Return on Equity fell 1100.0% to 0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.41% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Compass Therapeutics' Return on Equity is 0.46%, which was down 1100.0% from 0.65% recorded in Q2 2025.
  • Compass Therapeutics' 5-year Return on Equity high stood at 0.28% for Q4 2023, and its period low was 0.65% during Q2 2025.
  • Its 3-year average for Return on Equity is 0.41%, with a median of 0.37% in 2024.
  • Within the past 5 years, the most significant YoY rise in Compass Therapeutics' Return on Equity was -1100bps (2025), while the steepest drop was -3400bps (2025).
  • Over the past 3 years, Compass Therapeutics' Return on Equity (Quarter) stood at 0.28% in 2023, then crashed by -45bps to 0.4% in 2024, then dropped by -16bps to 0.46% in 2025.
  • Its Return on Equity was 0.46% in Q3 2025, compared to 0.65% in Q2 2025 and 0.5% in Q1 2025.